Keyphrases
Advanced Hepatocellular Carcinoma
100%
Sunitinib
100%
Tumor Density
100%
Response Evaluation Criteria in Solid Tumors (RECIST)
83%
Computed Tomography
50%
Hepatocellular Carcinoma
50%
Choi Criteria
50%
Tumor Size
33%
Partial Response
33%
Time to Progression
33%
Tumor Necrosis
33%
Tumor
16%
Radiologic
16%
Blood Volume
16%
Tumor Volume
16%
Response Rate
16%
Non-responders
16%
Median Time
16%
Targeted Therapy
16%
Surrogate Endpoint
16%
Hypodensity
16%
Density Assessment
16%
Volumetric Assessment
16%
Tumor Perfusion
16%
Perfusion Computed Tomography
16%
Tumor Blood Flow
16%
Perfusion Parameters
16%
Volumetric Reconstruction
16%
Medicine and Dentistry
Neoplasm
100%
Hepatocellular Carcinoma
100%
Sunitinib
100%
Response Evaluation Criteria in Solid Tumors
50%
Computer Assisted Tomography
30%
Tumor Necrosis
20%
Targeted Therapy
10%
Tumor Blood Flow
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Liver Cell Carcinoma
100%
Sunitinib
100%
Solid Malignant Neoplasm
45%
Tumor Necrosis
18%
Immunology and Microbiology
Sunitinib
100%
Tumor Volume
60%
Computer Assisted Tomography
60%
Perfusion
40%
Tumor Blood Flow
20%